Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

Continued use of poliovirus after eradication: hyper-attenuated strains as a safe alternative for release testing of human immunoglobulins.

Farcet MR, Modrof J, Rabel PO, Schirmer A, Macadam AJ, Fox H, Minor PD, Kreil TR.

Transfusion. 2018 Dec;58 Suppl 3:3084-3089. doi: 10.1111/trf.15048.

PMID:
30536436
2.

Environmental Surveillance Reveals Complex Enterovirus Circulation Patterns in Human Populations.

Majumdar M, Sharif S, Klapsa D, Wilton T, Alam MM, Fernandez-Garcia MD, Rehman L, Mujtaba G, McAllister G, Harvala H, Templeton K, Mee ET, Asghar H, Ndiaye K, Minor PD, Martin J.

Open Forum Infect Dis. 2018 Oct 1;5(10):ofy250. doi: 10.1093/ofid/ofy250. eCollection 2018 Oct.

3.

Report of the international conference on next generation sequencing for adventitious virus detection in biologicals.

Khan AS, Benetti L, Blumel J, Deforce D, Egan WM, Knezevic I, Krause PR, Mallet L, Mayer D, Minor PD, Neels P, Wang G.

Biologicals. 2018 Sep;55:1-16. doi: 10.1016/j.biologicals.2018.08.002. Epub 2018 Aug 6.

PMID:
30093175
4.

Detection of bovine viral diarrhoea virus nucleic acid, but not infectious virus, in bovine serum used for human vaccine manufacture.

Laassri M, Mee ET, Connaughton SM, Manukyan H, Gruber M, Rodriguez-Hernandez C, Minor PD, Schepelmann S, Chumakov K, Wood DJ.

Biologicals. 2018 Sep;55:63-70. doi: 10.1016/j.biologicals.2018.06.002. Epub 2018 Jun 23.

PMID:
29941334
5.

Isolation of Vaccine-Like Poliovirus Strains in Sewage Samples From the United Kingdom.

Majumdar M, Klapsa D, Wilton T, Akello J, Anscombe C, Allen D, Mee ET, Minor PD, Martin J.

J Infect Dis. 2018 Mar 28;217(8):1222-1230. doi: 10.1093/infdis/jix667.

7.

Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating Vaccines.

Fox H, Knowlson S, Minor PD, Macadam AJ.

PLoS Pathog. 2017 Jan 19;13(1):e1006117. doi: 10.1371/journal.ppat.1006117. eCollection 2017 Jan.

8.

A collaborative study to establish the 3rd WHO International Standard for hepatitis B virus for nucleic acid amplification techniques.

Fryer JF, Heath AB, Wilkinson DE, Minor PD; Collaborative Study Group.

Biologicals. 2017 Mar;46:57-63. doi: 10.1016/j.biologicals.2016.12.003. Epub 2017 Jan 10.

9.

Commutability of the World Health Organization International Standard for Human Cytomegalovirus: Standard or Assay.

Fryer JF, Morris CL, Almond NM, Minor PD.

J Clin Microbiol. 2016 Dec;54(12):3073. No abstract available.

10.

A collaborative study to establish the 1st WHO International Standard for Epstein-Barr virus for nucleic acid amplification techniques.

Fryer JF, Heath AB, Wilkinson DE, Minor PD; Collaborative Study Group.

Biologicals. 2016 Sep;44(5):423-33. doi: 10.1016/j.biologicals.2016.04.010. Epub 2016 Jul 22.

11.

A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology.

Fryer JF, Heath AB, Minor PD; Collaborative Study Group.

Biologicals. 2016 Jul;44(4):242-251. doi: 10.1016/j.biologicals.2016.04.005. Epub 2016 May 11.

12.

An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.

Minor PD.

Methods Mol Biol. 2016;1387:1-10. doi: 10.1007/978-1-4939-3292-4_1.

PMID:
26983727
13.

New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication.

Knowlson S, Burlison J, Giles E, Fox H, Macadam AJ, Minor PD.

PLoS Pathog. 2015 Dec 31;11(12):e1005316. doi: 10.1371/journal.ppat.1005316. eCollection 2015 Dec.

14.

Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing.

Mee ET, Preston MD, Minor PD, Schepelmann S; CS533 Study Participants.

Vaccine. 2016 Apr 12;34(17):2035-43. doi: 10.1016/j.vaccine.2015.12.020. Epub 2015 Dec 19.

15.

Development of Lentivirus-Based Reference Materials for Ebola Virus Nucleic Acid Amplification Technology-Based Assays.

Mattiuzzo G, Ashall J, Doris KS, MacLellan-Gibson K, Nicolson C, Wilkinson DE, Harvey R, Almond N, Anderson R, Efstathiou S, Minor PD, Page M.

PLoS One. 2015 Nov 12;10(11):e0142751. doi: 10.1371/journal.pone.0142751. eCollection 2015.

16.

Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.

Sanders BP, Oakes Ide L, van Hoek V, Liu Y, Marissen W, Minor PD, Wimmer E, Schuitemaker H, Custers JH, Macadam A, Cello J, Edo-Matas D.

Vaccine. 2015 Nov 27;33(48):6611-6. doi: 10.1016/j.vaccine.2015.10.091. Epub 2015 Nov 1.

PMID:
26529068
17.

Assaying the Potency of Influenza Vaccines.

Minor PD.

Vaccines (Basel). 2015 Feb 5;3(1):90-104. doi: 10.3390/vaccines3010090. Review.

18.

Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative.

Dunn G, Klapsa D, Wilton T, Stone L, Minor PD, Martin J.

PLoS Pathog. 2015 Aug 27;11(8):e1005114. doi: 10.1371/journal.ppat.1005114. eCollection 2015 Aug.

19.

High resolution identity testing of inactivated poliovirus vaccines.

Mee ET, Minor PD, Martin J.

Vaccine. 2015 Jul 9;33(30):3533-41. doi: 10.1016/j.vaccine.2015.05.052. Epub 2015 Jun 3.

20.

Live attenuated vaccines: Historical successes and current challenges.

Minor PD.

Virology. 2015 May;479-480:379-92. doi: 10.1016/j.virol.2015.03.032. Epub 2015 Apr 8. Review.

21.

Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent.

Li L, Deng X, Mee ET, Collot-Teixeira S, Anderson R, Schepelmann S, Minor PD, Delwart E.

J Virol Methods. 2015 Mar;213:139-46. doi: 10.1016/j.jviromet.2014.12.002. Epub 2014 Dec 11.

22.

Effect of formaldehyde inactivation on poliovirus.

Wilton T, Dunn G, Eastwood D, Minor PD, Martin J.

J Virol. 2014 Oct;88(20):11955-64. doi: 10.1128/JVI.01809-14. Epub 2014 Aug 6. Erratum in: J Virol. 2014 Dec;88(23):13928.

23.

Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease.

Cooper JK, Andrews N, Ladhani K, Bujaki E, Minor PD.

Vox Sang. 2013 Oct;105(3):196-204. doi: 10.1111/vox.12037. Epub 2013 Jun 16.

PMID:
23772892
24.

Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.

Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, Modlin JF, Patriarca PA, Sutter RW, Wright PF, Wassilak SG, Cochi SL, Kim JH, Thompson KM.

Risk Anal. 2013 Apr;33(4):606-46. doi: 10.1111/risa.12031. Epub 2013 Mar 28. Review.

PMID:
23550968
25.

Interruption of poliovirus transmission in Ghana: molecular epidemiology of wild-type 1 poliovirus isolated from 1995 to 2008.

Odoom JK, Forrest L, Dunn G, Osei-Kwasi M, Obodai E, Arthur-Quarm J, Barnor J, Minor PD, Martin J.

J Infect Dis. 2012 Oct 1;206(7):1111-20. doi: 10.1093/infdis/jis474. Epub 2012 Jul 24.

PMID:
22829642
26.

Expert review on poliovirus immunity and transmission.

Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, Modlin JF, Patriarca PA, Sutter RW, Wright PF, Wassilak SG, Cochi SL, Kim JH, Thompson KM.

Risk Anal. 2013 Apr;33(4):544-605. doi: 10.1111/j.1539-6924.2012.01864.x. Epub 2012 Jul 15. Review.

PMID:
22804479
27.

Polio vaccines and the eradication of poliomyelitis.

Minor PD.

Lancet. 2012 Aug 4;380(9840):454-5. doi: 10.1016/S0140-6736(12)60921-0. Epub 2012 Jul 4. No abstract available.

PMID:
22766208
28.

Application of deglycosylation to SDS PAGE analysis improves calibration of influenza antigen standards.

Harvey R, Hamill M, Robertson JS, Minor PD, Vodeiko GM, Weir JP, Takahashi H, Harada Y, Itamura S, Bamford P, Dalla Pozza T, Engelhardt OG.

Biologicals. 2012 Jan;40(1):96-9. doi: 10.1016/j.biologicals.2011.12.009. Epub 2012 Jan 12.

PMID:
22244521
29.

The polio-eradication programme and issues of the end game.

Minor PD.

J Gen Virol. 2012 Mar;93(Pt 3):457-74. doi: 10.1099/vir.0.036988-0. Epub 2011 Nov 29. Review.

PMID:
22128250
30.

Neurovirulence tests of three 17D yellow fever vaccine strains.

Minor PD.

Biologicals. 2011 May;39(3):167-70. doi: 10.1016/j.biologicals.2011.04.001. Epub 2011 May 4.

PMID:
21536454
31.

Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production.

Minor PD.

Clin Infect Dis. 2010 Feb 15;50(4):560-5. doi: 10.1086/650171. Review.

PMID:
20085485
32.

Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK.

Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, Colegate T, Fabry L, Heldens JG, Kino Y, Kistner O, Kompier R, Makizumi K, Medema J, Mimori S, Ryan D, Schwartz R, Smith JS, Sugawara K, Trusheim H, Tsai TF, Krause R.

Vaccine. 2009 May 14;27(22):2907-13. doi: 10.1016/j.vaccine.2009.02.064. Epub 2009 Feb 27. Review.

PMID:
19366582
33.

Standardisation of nucleic acid amplification assays used in clinical diagnostics: a report of the first meeting of the SoGAT Clinical Diagnostics Working Group.

Fryer JF, Minor PD.

J Clin Virol. 2009 Feb;44(2):103-5. doi: 10.1016/j.jcv.2008.11.007. Epub 2008 Dec 25. No abstract available.

PMID:
19111506
34.

Student pharmacists: don't forget the product labeling.

Minor PD, Cook GE.

J Am Pharm Assoc (2003). 2008 Nov-Dec;48(6):696, 700. doi: 10.1331/JAPhA.2008.08057. No abstract available.

PMID:
19019796
35.

Development of working reference materials for clinical virology.

Fryer JF, Baylis SA, Gottlieb AL, Ferguson M, Vincini GA, Bevan VM, Carman WF, Minor PD.

J Clin Virol. 2008 Dec;43(4):367-71. doi: 10.1016/j.jcv.2008.08.011. Epub 2008 Sep 26. Review.

PMID:
18823817
36.

Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient.

Odoom JK, Yunus Z, Dunn G, Minor PD, Martín J.

J Virol. 2008 Sep;82(18):9179-90. doi: 10.1128/JVI.00468-08. Epub 2008 Jul 2.

37.

Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease.

Matthews BG, Afzal MA, Minor PD, Bava U, Callon KE, Pitto RP, Cundy T, Cornish J, Reid IR, Naot D.

J Clin Endocrinol Metab. 2008 Apr;93(4):1398-401. doi: 10.1210/jc.2007-1978. Epub 2008 Jan 29.

PMID:
18230662
38.
39.

Human coronavirus 229E encodes a single ORF4 protein between the spike and the envelope genes.

Dijkman R, Jebbink MF, Wilbrink B, Pyrc K, Zaaijer HL, Minor PD, Franklin S, Berkhout B, Thiel V, van der Hoek L.

Virol J. 2006 Dec 28;3:106.

40.

Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.

Macadam AJ, Ferguson G, Stone DM, Meredith J, Knowlson S, Auda G, Almond JW, Minor PD.

J Virol. 2006 Sep;80(17):8653-63.

41.
42.

Novel parvovirus and related variant in human plasma.

Fryer JF, Kapoor A, Minor PD, Delwart E, Baylis SA.

Emerg Infect Dis. 2006 Jan;12(1):151-4.

43.

When can we stop using oral poliovirus vaccine?

Hull HF, Minor PD.

J Infect Dis. 2005 Dec 15;192(12):2033-5. Epub 2005 Nov 8. No abstract available.

PMID:
16288363
44.

Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations.

Afzal MA, Dussupt V, Minor PD, Pipkin PA, Fleck R, Hockley DJ, Stacey GN.

J Virol Methods. 2005 Jun;126(1-2):149-56.

PMID:
15847931
45.

Transgenic animals for the production of biological medicines.

Minor PD.

Dev Biol (Basel). 2004;118:165-9. No abstract available.

PMID:
15645687
46.

Virological issues in the use of cell therapies.

Minor PD.

Dev Biol (Basel). 2004;118:151-3.

PMID:
15645685
47.

Long-term excretion of vaccine-derived poliovirus by a healthy child.

Martín J, Odoom K, Tuite G, Dunn G, Hopewell N, Cooper G, Fitzharris C, Butler K, Hall WW, Minor PD.

J Virol. 2004 Dec;78(24):13839-47.

48.

Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.

Minor PD, Dunn G, Ramsay ME, Brown D.

J Med Virol. 2005 Jan;75(1):153-60.

PMID:
15543587
49.

Isolation of SV40 from the environment of a colony of cynomolgus monkeys naturally infected with the virus.

Bofill-Mas S, Albiñana-Giménez N, Pipkin PA, Minor PD, Girones R.

Virology. 2004 Dec 5;330(1):1-7.

50.

Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.

Baylis SA, Shah N, Minor PD.

J Virol Methods. 2004 Oct;121(1):7-16.

PMID:
15350727

Supplemental Content

Loading ...
Support Center